4-nitrophenylphosphate has been researched along with Carcinoma, Epidermoid in 2 studies
nitrophenylphosphate: RN given refers to mono(4-nitrophenyl) ester of phosphoric acid
4-nitrophenyl phosphate : An aryl phosphate resulting from the mono-esterification of phosphoric acid with 4-nitrophenol.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lappin, DF | 1 |
| Abu-Serriah, M | 1 |
| Hunter, KD | 1 |
| Sakakibara, N | 1 |
| Suzuki, K | 1 |
| Kaneta, H | 1 |
| Yoshimura, Y | 1 |
| Deyama, Y | 1 |
| Matsumoto, A | 1 |
| Fukuda, H | 1 |
2 other studies available for 4-nitrophenylphosphate and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Effects of recombinant human bone morphogenetic protein 7 (rhBMP-7) on the behaviour of oral squamous cell carcinoma: a preliminary in vitro study.
Topics: Antineoplastic Agents; Bone Morphogenetic Protein 7; Bone Morphogenetic Protein Receptors, Type I; B | 2015 |
Inhibition of Na+,K+-ATPase by cisplatin and its recovery by 2-mercaptoethanol in human squamous cell carcinoma cells.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Dose-Response Relationship, Drug; Enzyme | 1999 |